Abstract
The innate immune system has evolved to detect microbes and sterile tissue damage with the help of a series of signaling receptors. One key strategy is to detect infectious microbes or host cell damage by recognizing nucleic acids that are modified or appear in compartment normally devoid of nucleic acids. Here, we describe two methods that allow studying the molecular interaction between various nucleic acid recognizing signaling receptors with their ligands. A ligand pull-down assay can be used to show a known interaction between a ligand and its receptor or the method can be utilized as a discovery approach to identify an unknown receptor to a given ligand. An AlphaScreen experiment can be set up to assess the ligand binding affinity to a given receptor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Rock, K.L., Latz, E., Ontiveros, F. & Kono, H. The sterile inflammatory response. Annu Rev Immunol 28, 321–342 (2010).
Hornung, V. & Latz, E. Intracellular DNA recognition. Nat Rev Immunol 10, 123–130 (2010).
Pisetsky, D.S. The role of innate immunity in the induction of autoimmunity. Autoimmunity reviews 8, 69–72 (2008).
Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu Rev Immunol 21, 335–376 (2003).
Takeuchi, O. & Akira, S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 20, 17–22 (2008).
Ablasser, A., et al. RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nat Immunol 10, 1065–1072 (2009).
Chiu, Y.H., Macmillan, J.B. & Chen, Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 138, 576–591 (2009).
Ewald, S.E., et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456, 658–662 (2008).
Park, B., et al. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat Immunol 9, 1407–1414 (2008).
Sepulveda, F.E., et al. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 31, 737–748 (2009).
Burckstummer, T., et al. An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome. Nat Immunol 10, 266–272 (2009).
Fernandes-Alnemri, T., Yu, J.W., Datta, P., Wu, J. & Alnemri, E.S. AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458, 509–513 (2009).
Hornung, V., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458, 514–518 (2009).
Latz, E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol 22, 28–33 (2010).
Alagkiozidis, I., et al. Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18. J Transl Med 7, 104 (2009).
Haas, T., et al. The DNA sugar backbone 2′ deoxyribose determines toll-like receptor 9 activation. Immunity 28, 315–323 (2008).
Schlee, M., et al. Recognition of 5′ triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31, 25–34 (2009).
Latz, E., et al. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol 8, 772–779 (2007).
Tian, J., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8, 487–496 (2007).
Latz, E., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 5, 190–198 (2004).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Stutz, A., Bertheloot, D., Latz, E. (2011). Innate Immune Receptors for Nucleic Acids. In: Rast, J., Booth, J. (eds) Immune Receptors. Methods in Molecular Biology, vol 748. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-139-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-61779-139-0_5
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-138-3
Online ISBN: 978-1-61779-139-0
eBook Packages: Springer Protocols